| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $494.6M | +12.3% |
| Cost of Revenue | $283.1M | +10.8% |
| Gross Profit | $211.6M | +14.3% |
| R&D Expense | $9.8M | -7.3% |
| SG&A Expense | $123.8M | +5.8% |
| Operating Income | $75.4M | +36.6% |
| Pre-tax Income | $67.7M | +37.5% |
| Income Tax | $16.1M | +3.3% |
| Net Income | $51.6M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.6M | +36.5% |
| Accounts Receivable | $107.3M | +9.9% |
| Inventory | $86.3M | +5.1% |
| Current Assets | $274.6M | +9.4% |
| Total Assets | $767.7M | +18.2% |
| Current Liabilities | $109.3M | -0.7% |
| Long-term Debt | $167.5M | +70.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.0M | +14.3% |
| Capital Expenditures | $11.0M | +16.5% |
| Investing Cash Flow | -$109.5M | -145.8% |
| Financing Cash Flow | $56.5M | +519.9% |
| Free Cash Flow | $54.9M | +13.8% |
| +53.2% |
| EPS (Basic) | $1.53 | +51.5% |
| EPS (Diluted) | $1.51 | +51.0% |
| Total Liabilities |
| $292.9M |
| +27.0% |
| Stockholders' Equity | $474.9M | +13.3% |